Canada Clinical Diagnostics Market Analysis Sample Report

Canada Clinical
Diagnostics Market
Analysis
A Sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Canada Clinical
Diagnostics Market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, types of clinical diagnostics, point-of-care testing,
main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Canada Clinical
Diagnostics Market, and offers unmatched value, accuracy, and expert
insights

Table of
Contents
• Market Overview
• Market Size and Forecasts
• Growth Drivers & Restraints
• Types of Clinical Diagnostics
• Market Segmentation
• Point-of-Care Testing
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth

4 A Report on Canada Clinical Diagnostics Market Analysis I Confidential
Table of Contents
1. Canada Clinical Diagnostics Market overview……………..………………………………………….…………...…………………………….07
1.1 Patient Journey Through Diagnostics In Canada
1.2 Geographical Distribution Of Healthcare Delivery
2. Market Size & Forecasting……………………………………………………………………………………………………………………………10
2.1 Market Size, Growth Prospects, and Key findings, 2022-2030
3. Market Growth Drivers and Restraints …………………………………………………………………..….…….………………………………12
3.1 Market Growth Drivers
3.1.1 Increasing Prevalence of Diseases
3.1.2 Growing Awareness about Early Disease Detection
3.1.3 Government Initiatives and Investments
3.2 Market Restraints
3.2.1 Delayed in Diagnosis
3.2.2 Shortage of Diagnosis Equipment
3.2.3 Data Privacy Concerns
4. Types of Clinical Diagnostics Test……...……………….………………………………..……………….……………………………...........….18
4.1 Laboratory Test
4.2 Imaging Test
4.3 Molecular Diagnostics

Table of Contents (continued)
5. Market Segmentation………………………………………………………………………………………………………………………………….24
5.1 By Molecular Diagnostics
5.1.1 Polymerase Chain Reaction
5.1.2 Next Generation Sequencing
5.1.3 Isothermal Nucleic Acid Amplification Technology
5.1.4 Microarray
5.1.5 In-situ Hybridization
5.1.6 Immunohistochemistry
5.1.7 Other technologies
5.2 By End User
5.2.1 Hospital Laboratory
5.2.2 Diagnostic Laboratory
5.2.3 Point-of-care Testing
6. Point-Of-Care Testing………………………………………………………………………………………………...……….…...……………...….27
6.1 Point-Of-Care Testing
6.2 Point-Of-Care Testing- Key Players
6.3 Point-Of-Care Testing- Key Company Profile
7. Competitive Landscape…………………………………………………………………………………………………….……...……………...….37
7.1 Key Players

Table of Contents (continued)
8. Key Company Profiles………………………………………………………………………………………...…………………..………….…........41
8.1 LifeLabs
8.2 SickKids Hospital
8.3 Dynacare
8.4 MIC Medical Imaging
8.5 Public Health Ontario
8.6 Biron
8.7 Akumin
8.8 Alpha Labs
8.9 EFW Radiology
9. Healthcare Policies and Regulatory Landscape…………………………….….………………………………………………...……………...51
9.1 Healthcare Policies and Regulatory Framework in Canada
9.2 Government Initiatives for Clinical Diagnostic
9.3 Pricing & Reimbursement Scenario in Canada Clinical Diagnostics Market
10. Factors Driving Future Growth…..……………………….……………………………………………………………….……………………….55
10.1 New Trends and Development Canada Clinical Diagnostics Market
10.2 Future Opportunities

Canada Clinical Diagnostics Market Analysis
1. Overview

1.1 Patient Journey Through Diagnostics In Canada
Patient
Physician
Laboratory Test/Imaging
Test/Molecular Diagnostic
Pathologist/Radiologist
Patient sees family
doctor or specialist
Pathologist/Radiologist produces
a report and sends it to referring
physician
Report contains summary of
findings, possible diagnoses,
and recommended next steps
Next Step
Based on the radiologist's report,
the referring physician decides on
the next steps for patient
Physician sends patient
for medical imaging
Results get sent to pathologist/
radiologist for review and analysis

Key Insights
1.2 Geographical Distribution Of Healthcare Delivery
The map shows the population density and wide geographical distribution of health-care delivery. Hospital data for Canada are from DMTI Spatial, 2016, and population data for Canada are from Statistics Canada, 2016
▪ Geographic difficulties facing Canada's healthcare system
are significant
▪ Canada covers over 95% of the territory of the second-
largest country in the world and about 18% of Canadians
reside in rural or remote communities
▪ Health care delivery is difficult and expensive across the
north of the densely populated Canada-USA border
corridor due to the requirement for far-flung primary care
facilities and frequent medical transport to specialized
centres
▪ In Canada, only 13.6% of family doctors and less than 3%
of specialists reside in rural and remote areas, indicating
that the distribution of healthcare professionals and
resources do not correspond to the needs
▪ For nurses and other regulated health-care professionals,
there are comparable distributional imbalances
Population density and distribution of hospitals in Canada

2. Market Size & Forecasting

2.1 Canada Clinical Diagnostics market size to reach $4.92Bn in 2030
▪ Canada Clinical Diagnostics market size stands at around
$3.9 Bn in 2022 and is projected to reach $4.9 Bn by 2030,
exhibiting a CAGR of 3.1% during the forecast period
▪ Around 7,024 medical and diagnostic laboratory companies
are present in Canada
▪ Major factors driving the market growth includes the
increasing prevalence of diseases and increasing awareness
amongst the patients for early diagnosis
▪ Increased government expenditure helps patients to get
access to diagnostic services in the country
▪ Shortage of diagnosis equipment and data privacy concerns
might hamper the market growth
Key Analysis

3. Growth Drivers & Restraints

Key Growth Drivers
3.1 Market Growth Drivers
3.1.3 Government
initiatives and
investments
3.1.2 Growing
awareness about early
disease detection
3.1.1 Increasing
Prevalence of
Diseases

3.1 Market Growth Drivers (continued)
3.1.1 Increasing Prevalence of Diseases
▪ In 2020, 4% of Canadians
reported having received a
COPD diagnosis from a
medical professional, also the
death rate from cirrhosis and
chronic liver disease was 7.2
per 100,000 Canadians
Chronic Diseases
▪ There were around 233,900
new cancer cases and
85,100 cancer deaths in
Canada in 2022. Cancer is
the leading cause of death in
Canada and is responsible
for 28.2% of all deaths
Cancer
▪ Around 2.4 out of every
100,000 Canadians died in
2020 as a result of
unspecified infectious and
parasitic diseases and their
consequences
Infectious Diseases
Sample Sample Sample

3.1.2 Growing awareness about early disease detection
Increasing
awareness about the
importance of early
disease detection
and the benefits of
early treatment is
driving the growth of
the Canadian clinical
diagnostics market
Also during the
Omicron wave, PCR
test capacity limits
were reached in
Canada, and COVID-
19 fast testing saw a
sharp rise in demand
Sample
Sample

3.1.3 Government initiatives and investments
Addition of 27 new
MRI devices in
hospitals across
Ontario will be
supported by an
investment of over
$20 Mn in operating
money from the
Ontario government
Some small and
remote community
hospitals will now be
able to use their very
first MRI machine as
a result of this
investment and it
means that residents
of these communities
will have easier
access to diagnostic
imaging
Federal government
proposed Bill C-17 in
the House of
Commons, which
would give provinces
and territories an
extra $2 Bn as a one-
time top-up, split
equally per
population
Sample

3.2 Market Restraints
3.2.1 Delayed in Diagnosis
▪ Across the 10 provinces in Canada, the
total number of procedures for which
people are waiting in 2022 is 1,228,047
3.2.3 Data Privacy Concerns
▪ Growing concerns about data privacy
and security are a restraint to the
growth of the Canadian clinical
diagnostics market, as the storage and
use of sensitive patient information is a
major concern
3.2.2 Shortage of Diagnosis
Equipment
▪ Canadians have struggled for years to
get timely access to medical imaging
(MI)
Sample Sample
Sample

4. Types of Clinical Diagnostics Test

4.1 Laboratory Test
Top most commonly ordered laboratory tests in Canada
Community Inpatient Emergency
Complete blood count Creatinine
Thyroid stimulating hormone Electrolyte panel
Alanine amino-transferase Hemoglobin A1c
LDL cholesterol Ferritin
Urinalysis with microscopic Others
Complete blood count Electrolyte panel
Creatinine Magnesium
Phosphate Scan with morphology
Urea Prothrombin time (INR)
Calcium Others
Sample
Complete blood count Chem panel 7
Creatinine Electrolyte panel
Liver panel Troponin-T
Prothrombin time (INR) Urinalysis with microscopic
Blood culture Others
Sample Sample

4.2 Imaging Test
▪ Imaging tests in Canada include: X-rays, CT (Computed Tomography) scans, MRI (Magnetic Resonance Imaging) scans
Ultrasound, PET (Positron Emission Tomography) scans, Nuclear imaging & Mammogram
▪ In 2022, it was estimated that 28,600 Canadian women will be diagnosed with breast cancer ultimately raising the demand
for Mammography Imaging as well as services
▪ In August 2022, through a collaboration with Synthesis Health, Pelican Narrows and two additional Peter Ballantyne Cree
Nation (PBCN) towns, Deschambault Lake and Southend, the first ultra portable X-ray equipment was installed in Canada
Imaging Test 2017 2020 2030
Computed Tomography Scan (CT) in Mn 5.6 6.6 9.2
Magnetic Resonance Imaging (MRI) in Mn
1.8 2.7 3.9
Positron Emission Tomography (PET) in Mn 0.09 0.126 0.128
Number of diagnostics expected to be performed in Canada (in Mn)

4.2 Imaging Test (continued)
2015 2016 2017 2018 2019 2020 2021 2022
MRI CT-Scan Ultrasound
Number of weeks patients had to wait to receive the following in Canada from 2015 to 2022
In all provinces of Canada, patients experience significant waiting times for various diagnostic services
In 2022, the average wait time for a computed tomography (CT) scan was 5.4 weeks, 10.6 weeks for an MRI scan, and 4.9
weeks for an ultrasound
This exceeds the normal 30-day waiting period for these potentially life-saving treatments by 20 to 52 days

4.3 Molecular Diagnostics
Molecular diagnostic tests are laboratory tests that employ molecular biology techniques to detect particular genetic
material (DNA or RNA) or protein or other molecule linked with a condition or disorder from the sample of tissue, blood, or
other body fluids
Polymerase chain reaction (PCR)
Real-Time RT-PCR
Next-generation sequencing (NGS)
In-situ hybridization (ISH)
Fluorescence In-Situ Hybridization (FISH)
Chromogenic in situ hybridization (CISH)
Immunohistochemistry
Array-based comparative genomic
hybridization
Molecular Diagnostic methods Molecular Diagnostics applications
Oncology ( BRCA1, BRCA2, HER2, EGFR,
KRAS)
Infectious diseases (SARS-CoV-2,Flu A/B &
RSV)
Inherited genetic disorders (cystic fibrosis,
sickle cell anaemia, down's syndrome and
Huntington's disease)
Disease progression monitoring
Personalized medicine formulation
Reproductive Testing – Non-invasive
Prenatal Tests (NIPT), IVF, New born
screening

4.3 Molecular Diagnostics (continue)
Analyzers
POINT OF
CARE
MOLECULAR
DIAGNOSTICS
Respiratory
Diseases
Research and
Academic Institutes
Hospital Outpatient
Departments and
ICUs
Prenatal/Neonatal
Testing
Clinics and
Diagnostic
Laboratories
Sexual Transmitted Diseases
(STDs)
Cancer/Oncology ▪ Point-of-care (POC) molecular
diagnostics refers to portable tools,
tests, and kits that are used to identify
and classify diseases in human
samples such as faeces, blood, serum,
and throat swabs
▪ POC molecular testing is replacing
centralized laboratories in molecular
diagnostics
▪ POC testing is quickly gaining
acceptance because of its ease of use,
comfort, quick turnaround time, and
potential to enhance patient outcomes
▪ These benefits allow it to be used for
diagnostics in rural or underdeveloped
places

5. Market Segmentation

Key Insights
5.1 Market Segmentation: By Molecular Diagnostics
Polymerase chain reaction
(PCR)
Next-generation sequencing
Isothermal nucleic acid
amplification technology (INAAT)
Microarray
In-situ hybridization (ISH)
Immunohistochemistry (IHC)
Other technologies
Sample
▪ Molecular diagnostics is a rapidly growing field in
Canada that utilizes techniques such as polymerase
chain reaction (PCR), next-generation sequencing
(NGS), and gene expression analysis to detect and
analyze genetic material
▪ Goal of molecular diagnostics is to provide fast and
accurate results that enable healthcare providers to
diagnose and treat diseases effectively
Other technologies*- Real-Time RT-PCR, Fluorescence In-Situ Hybridization (FISH) tests,
chromogenic in situ hybridization (CISH),Blot tests, Array Comparative Genomic Hybridization
(aCGH)
Distribution Of Molecular Diagnostics in Canada
Sample

Key Insights
5.2 Market Segmentation: By End User
Canada Clinical Diagnostics Market Share
(By End User)
Diagnostic Laboratory
Hospital
POC
▪ Based on end user, the laboratories segment has a
66% market share in Canada
▪ Laboratories are important settings for clinical
diagnostics, where a wide range of tests are performed
using advanced diagnostic equipment and techniques
Sample
Sample

6. Point-Of-Care Testing

6.1 Point-Of-Care Testing
▪ Point-of-care testing (POCT) describes diagnostic procedures carried out by a medical professional or other qualified
personnel at or close to the patient's location
▪ This can include tests carried out by patients independently in a community or at home (patient self-testing)
▪ POCT can be carried out in a variety of locations, including clinics, hospitals, doctor's offices, pharmacies, ambulances,
nursing homes, long-term care facilities, and patients' homes
▪ Compared to conventional testing, it might be more advantageous because it allows for greater staff and patient mobility,
portability between urban and rural settings, and quick turnaround for test results. These elements might hasten clinical
judgement and patient management while boosting effectiveness
▪ Use of POCT in healthcare has increased recently, and this development is anticipated to continue
▪ Canadian states and territories are looking for ways to implement POCT in the delivery of healthcare in a way that is
appropriate and efficient in view of this expansion. There are still loopholes in some topics, including the cost-effectiveness,
quality, and reliability of POCT as well as the effects of POCT adoption on the healthcare system
Understanding Of Point-Of-Care Testing

Key Insights
6.1 Point-Of-Care Testing (continued)
POC Diagnostics Market Share By Indication
Hematology Testing
Cardiometabolic Diseases
Others
Pregnancy & Infertility
Testing
Infectious Diseases
Blood Glucose Monitoring
▪ Increased prevalence of diabetes and cancer, the use of novel
point-of-care diagnostics, and the preference for at-home
glucose testing all contribute to the expansion of the blood
glucose monitoring market
Other*- Hyperthyroidism, Oxygen Testing, assessment for developing contrast-
induced nephropathy (CIN), Colorectal cancer screening, Dipstick urinalysis
Sample
Sample

▪ In some provinces and territories, information about tests
used for POCT is not publicly accessible
▪ Colleges of Physicians and Surgeons' provincial laboratory
standards, which are available to the public, only distinguish
between POCTs that need laboratory accreditation and
those that don't in two provinces: Alberta and British
Columbia
Point-of-Care Tests in Use in Canada Canadian Standards and Guidelines Related to Point-
of-Care Testing
Key POC Testing Areas
Blood glucose monitoring for diabetes
Cholesterol testing
Pregnancy testing
HIV-I and HIV-2 antibody test
Urine dipstick test
Key Players in Canadian Market
Sample

Community-based point-of-care testing policy (British Columbia)
British Columbia Ministry of Health (the Ministry) regulates and influences the provision and utilization of POCT in particular
medical/clinical domains through accreditation standards for diagnostic service providers and scope of practice regulations that specify
which healthcare professionals are allowed to perform tests, interpret results, make diagnoses, and manage treatments. This is done
to ensure the quality and safety of care in these settings
Scope:
Sample

6.2 Point-Of-Care Testing- Key Players
Top Point-Of-Care Testing Companies In Canada
# Company Revenue ($ Mn) Headquarter
1 Abbott Laboratories xx Chicago, Illinois, US
2 BD (Becton, Dickinson and Company) xx
Franklin Lakes, New
Jersey, US
3 Roche Diagnostics xx Basel, Switzerland
4 Siemens Healthcare xx Erlangen, Germany
5 Cepheid (a subsidiary of Danaher Corporation) xx California, US
6 EKF Diagnostics Holdings plc xx Cardiff, UK
7 bioMérieux xx Marcy-l'Étoile, France
8 Hologic Inc xx Marlborough, US
9 Thermo Fisher Scientific xx Waltham, US

6.3 Point-Of-Care Testing: Key Company Profile
Company: Abbott Laboratories
Headquarter: Chicago, Illinois, US
Year of Establishment: 1888
Revenue: $43.7 Bn (2022)
Website: www.abbott.com
Blood
Analyzer
Covid-19
Infectious
Diseases
Lipid
Testing
Rapid Drug
Screening
Malaria
Test
IVF
i-STAT 1
PANBIO™
COVID-19
Ag
ID NOW™
AFINION™
2
SoToxa™
BINAXNOW
™
MALARIA
BINAXNOW
™
INFLUENZ
A A&B
CARD
i-STAT
ALINITY
ID NOW™
COVID-19
2.0
CHOLESTE
CH LDX™
NxTek™
ELIMINATE
MALARIA
P.f
Abbott Laboratories Product Portfolio

6.3 Point-Of-Care Testing: Key Company Profile (continued)
Company: Becton, Dickinson and Company
Headquarter: Franklin Lakes, New Jersey, US
Revenue: $18.7 Bn (2022)
Website: www.bd.com
Siemens Healthineers Product Portfolio
BD Veritor™ Plus Analyzer
Rapid Detection of SARS-CoV-2* kit
Rapid Detection of Flu A+B
Rapid Detection of Group A Strep
Rapid Detection of RSV
BD InfoWiFi module

Company: Roche Diagnostics
Headquarter: Basel, Switzerland
Revenue: $19.1 Bn (2022)
Website: www.rochecanada.com
Cardiovascul
ar Testing
Urine Testing
Cobas POC
IT Solution
Coagulation
Testing
Blood
Glucose
Testing
HbA1c and
Lipid Panel
Testing
cobas h 232 Urisys 1100 cobas IT 1000
Coaguchek
XS
Accu-Chek
Inform II
cobas b 101
Coaguchek
XS Pro
Roche Diagnostics Product Portfolio

Company: Siemens Healthineers
Headquarter: Erlangen, Germany
Revenue: $23.1 Bn (2022)
Website: www.siemens-healthineers.com
Siemens Healthineers Product Portfolio
Blood Gas
Systems
Cardiac
Systems
Diabetes
Analyzers
POC Urinalysis
Systems
Informatics
Solutions
epoc® NXS Host
Stratus® CS 200
Acute Care™
DCA Vantage®
CLINITEK
Status®+
POCcelerator™
RAPIDPoint®
500e
Atellica®
CLINITEK
Status®
POCcelerator™
SE
RAPIDLab®
1200
CLINITEK
Advantus®
UniPOC™
RAPIDLab®
348EX
epoc®
RAPIDPoint®
500

7. Competitive Landscape

7.1 Key Players
Company Key Insights
▪ In December 2022, LifeLabs announced a new partnership with Natera, Inc., a global
pioneer in cell-free DNA testing, to provide individualized cancer testing in Canada via
Natera's SignateraTM Residual Disease Test & in the same year, also introduced a new
patient service center in Kanata, Ottawa
▪ They support 20 Mn patient visits annually and conduct over 100 Mn laboratory tests
▪ January 2023, SickKids ranked as one of Canada's Top 40 Research Hospitals, as first for
hospital intensity and also for researcher intensity for the year 2022
▪ One of their breakthrough study demonstrated how whole genome sequencing, implemented
as a standard of care, might offer the diagnostic answers that physicians needed while also
opening up new paths for therapy in less time than current testing allows
▪ Dynacare provides a comprehensive variety of laboratory testing services, including regular
and specialized tests in hematology, clinical chemistry, immunology, and genetics to over
165 patient care centers across Quebec, Ontario, Manitoba, Alberta and British Columbia in
Canada
▪ In June 2022, InsideTracker, the leading, completely individualized performance and nutrition
solution, announced a partnership with Dynacare

7.1 Key Players (continued)
▪ MIC has been an important provider of health care services in Northern Alberta, running 13
community-based imaging clinics and supplying contract services to 12 Edmonton area
hospitals and community health centers
▪ In September 2021, PocketHealth, the creator of healthcare's most innovative digital image
sharing solution, announced how MIC Medical Imaging opted its platform to make diagnostic
image sharing more accessible for patients
▪ On 8th February 2023, The Clinical and Laboratory Standards Institute (CLSI) awarded
PHO's laboratory the 2023 Excellence in Member Organization Leadership Award
▪ PHO assumed leading role in the Ontario COVID-19 Genomics Network and the COVID-19
Testing Strategy Expert Panel, in addition to participation in the COVID-19 Provincial
Diagnostic Network in Ontario
▪ In December 2022, Biron Health Group's medical biology laboratory received a certification
from the Standards Council of Canada for the ISO 15189 standard Medical labs -
Requirements for quality and competence, after a conformity evaluation by the “Bureau de
normalization du Québec”

7.1 Key Players (continued)
▪ June 2021, Akumin Inc., made a strategic partnership with Philips to install the new
Radiology Operations Command Center across Akumin's urgent care imaging centers and
co-create clinical standards for Akumin's MR and CT imaging technologies
▪ AlphaLabs utilizes OLIS (Ontario Laboratories Information System) to electronically collect,
utilize, and disclose lab requisitions and findings. Health care professionals may utilize OLIS
to acquire and communicate lab test information to one another

8. Key Company Profiles

8.1 LifeLabs
Website: www.lifelabs.com
Total Revenue: $977.9 Mn
Company Name: LifeLabs
Company at a Glance
Company’s Portfolio
Headquarter: Toronto, Ontario, Canada

8.2 SickKids
Website: www.sickkids.ca
Total Revenue: $1.1 Bn
Hospital Name: SickKids
Company at a Glance
Hospital Portfolio

8.3 Dynacare
Headquarter: Ontario, Canada
Website: www.dynacare.ca
Company Name: Dynacare
Company at a Glance

8.4 MIC Medical Imaging
Headquarter: Alberta, Canada
Website: www.mic.ca
Company Name: MIC Medical Imaging
Company at a Glance

8.5 Public Health Ontario
Headquarter: Ontario, Canada
Website: www.publichealthontario.ca
Company Name: Public Health Ontario
Company at a Glance

8.6 Biron
Headquarter: Quebec, Canada
Website: www.biron.com
Company Name: Biron
Company at a Glance

8.7 Akumin Inc
Website: www.mic.ca
Company Name: Akumin Inc
Company at a Glance

8.8 AlphaLabs
Website: https://alphalabs.ca/
Company Name: AlphaLabs
Company at a Glance

8.9 EFW Radiology
Headquarter: Calgary, Alberta, Canada
Website: www.efwrad.com
Total Revenue: $150 Mn
Company Name: EFW Radiology
Company at a Glance

9. Healthcare Policy and Regulatory Landscape

9.1 Healthcare Policies & Regulatory Framework
▪ Federal legislation first approved in 1957 and again in 1966 created Canada's universal, publicly funded healthcare system
▪ The Canada Health Act of 1984 replaces and combines the two earlier acts, and it establishes national standards for hospital, diagnostic,
and physician services that are medically required
▪ The Health Products and Food Branch (HPFB) of Health
Canada handles health-related risk and ensures that the
regulatory system for foods and health products is safe as
possible & offers reliable, scientifically supported health
decisions
▪ Canada's medical devices are federally regulated by
Health Canada’s Medical Devices Bureau
Sample Sample

9.2 Government Initiatives for Clinical Diagnostics
Standards Council Of Canada (SCC)
▪ SCC is a crown organization created in 1970 as a result
of a Act passed by Parliament with the goal of
encouraging and advancing voluntary standardization in
Canada
Canada Health Infoway
▪ Canada Health Infoway is an independent, not-for-profit
organization funded by federal government
Sample Sample

9.3 Pricing and Reimbursement Scenario
All Canadian citizens and permanent residents have access to a publicly funded healthcare system in Canada. But almost two-
thirds of population have private insurance as the universal medical public health insurance only covers the most basic needs
Sample
Sample
Sample
Sample

10. Factors Driving Future Growth

10.1 New Trends and Development
▪ AI-based software
programs examine
vast amounts of
patient data and
previous therapies to
identify what is
optimal for a patient
▪ IoT in healthcare
involves wearable
and implanted
devices that are
connected to
patients' bodies
requiring
minimal human
intervention
▪ Big data analytics
applications and
systems produce
deeper insights of
the disease
mechanism, analyze
disease data, and
forecast early effects
on patients
▪ Blockchain
eliminates the need
for central data
repository by
creating a
decentralized
ecosystem to which
everyone has instant
access to data and
can promptly
diagnose illnesses
▪ With the advent of
cloud computing,
telehealth services
have undoubtedly
improved in quality
▪ By building a virtual
world using VR
navigation tests and
analyzing the
findings, virtual
reality is used to
diagnose the early
stages of mental
illness
AI Based Software
Platforms
Big Data & Analysis Blockchain Cloud Computing Virtual Reality
Healthcare IoT or
IoMT
Sample
Sample
Sample
Sample
Sample
Sample

10.2 Future Opportunities
Addressing Contemporary Healthcare Issues
Artificial Intelligence at Forefront
Innovation Supports Precision Medicine
Sample
Sample
Sample

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify
the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Mn/Bn (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and healthcare
sector at global, regional as well as country level. We
also provide customized research reports tailor made
to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market research
firm founded with an aim of being an insights driven
company in the data driven world and delivering
actionable insights that can drive decision and
strategy making process for businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

Canada Clinical Diagnostics Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Canada Clinical Diagnostics Market Analysis Sample Report

Similar to Canada Clinical Diagnostics Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Canada Clinical Diagnostics Market Analysis Sample Report